Literature DB >> 11734966

Diffusion-weighted MR imaging of Carmofur-induced leukoencephalopathy.

A Fujikawa1, K Tsuchiya, S Katase, Y Kurosaki, J Hachiya.   

Abstract

Carmofur (1-hexylcarbamyl-5-fluorouracil), a derivative of 5-fluorouracil (5-FU), has been widely used in Japan as a postoperative adjuvant chemotherapy agent for colorectal and breast cancer. Periventricular hyperintensity on T2-weighted MR images in carmofur-induced leukoencephalopathy confront the physician with a broad range of differential diagnoses. We describe two cases of carmofur-induced leukoencephalopathy in which diffusion-weighted MR imaging revealed periventricular hyperintensity. We compared their findings with those of age-related periventricular hyperintensity in five patients and found discrepancies in signal intensity of periventricular areas. Our results suggest that diffusion-weighted MR imaging may be useful to differentiate carmofur-induced leukoencephalopathy from age-related periventricular hyperintensity.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11734966     DOI: 10.1007/s003300100955

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  4 in total

Review 1.  Diffusion-weighted MRI in neuro-oncology.

Authors:  Joachim M Baehring; Robert K Fulbright
Journal:  CNS Oncol       Date:  2012-11

2.  Transient splenial lesion of the corpus callosum associated with antiepileptic drugs: evaluation by diffusion-weighted MR imaging.

Authors:  Masayuki Maeda; Takashi Shiroyama; Hirokazu Tsukahara; Taro Shimono; Shigeki Aoki; Kan Takeda
Journal:  Eur Radiol       Date:  2002-10-12       Impact factor: 5.315

3.  Systemic 5-fluorouracil treatment causes a syndrome of delayed myelin destruction in the central nervous system.

Authors:  Ruolan Han; Yin M Yang; Joerg Dietrich; Anne Luebke; Margot Mayer-Pröschel; Mark Noble
Journal:  J Biol       Date:  2008-04-22

4.  Substrate Reduction Therapy for Krabbe Disease: Exploring the Repurposing of the Antibiotic D-Cycloserine.

Authors:  Steven M LeVine; Sheila Tsau
Journal:  Front Pediatr       Date:  2022-01-18       Impact factor: 3.418

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.